Georgia Lawmakers Consider Funding Research on How Psychedelics Might Help Veterans

FacebookXPinterestEmailEmailEmailShare
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber"
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber" in the basement of a private home on July 28, 2023, in Fairfield County, Connecticut. (John Moore/Getty Images/TNS)

ATLANTA — A bipartisan panel of Georgia lawmakers on Wednesday endorsed a plan recommending the state spend up to $5 million studying the effects of ecstasy, psychedelic mushrooms and other mind-altering drugs on mental health treatments for military veterans.

The proposal was one of 16 recommendations from the Senate Study Committee on Veterans, Mental Health and Housing. And while it sounds radical, Georgia would not be the first state to do something like this.

Oregon and Colorado have already legalized psilocybin, the psychedelic compound found in some mushrooms. And last year the California Legislature passed a bill that would have legalized possession of certain psychedelics — only for it to be vetoed by Democratic Gov. Gavin Newsom.

“Veterans who suffer from post-traumatic stress and brain injuries have very few reliable options for treatment,” said state Sen. Josh McLaurin, a Democrat from Atlanta and a member of the panel that endorsed the plan. “A growing body of research shows that psychedelics — when administered carefully in clinical settings — may be a total game changer.”

Lawmakers heard testimony from veterans who have traveled outside the United States for treatment. Still, it’s been difficult to win over Georgia’s mostly conservative Legislature, where many members have spent a lifetime preaching the “just say no” doctrine of illegal drugs.

The committee’s recommendation is a baby step toward funding. Any budget allocation would have to be vetted and approved by the General Assembly. That discussion is likely to be more precarious, but the endorsement from this panel shows there is growing support for the idea.

Post-traumatic stress disorder is more common among military veterans, especially those who have faced life-threatening situations in combat. The symptoms — including nightmares, severe anxiety and difficulty concentrating and sleeping — are difficult to treat.

Researchers, including those at Atlanta’s Emory University, have been studying how psychedelics, when combined with psychotherapy, can help patients.

A crucial component of the debate is the mainstream acceptance of the idea, which has been slowly gaining steam as more influential people get on board. That includes Bob Parsons, a Vietnam veteran and the founder of the internet domain registry GoDaddy who has invested millions of his own dollars to support research.

That was enough to convince state Sen. Ed Harbison, D-Columbus, who said he had been hesitant about the idea at first but is more open to supporting it now.

The U.S. Department of Veterans Affairs’ top doctor has said the agency is ready to administer the therapy as soon as it’s approved by regulators. But that was derailed in August after federal regulators declined to approve MDMA, also known as ecstasy or molly, as a treatment for post-traumatic stress disorder.

Other recommendations from the panel included temporarily waiving or reducing property taxes for returning veterans and creating a program to help service members navigate the complexities of the health care system.

_____

(Staff writer Greg Bluestein contributed to this article.)

_____

©2024 The Atlanta Journal-Constitution. Visit at ajc.com. Distributed by Tribune Content Agency, LLC.

Story Continues